Characterization of Aβ aggregation mechanism probed by congo red

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Beta-amyloid peptide (Aβ) aggregation is a primary cause of neuronal toxicity and Alzheimer's disease (AD).
• The effect of Congo Red (CR) on Aβ aggregation is debated, with studies showing both promotion and prevention.
• CR's ability to interact with different Aβ conformations makes it a valuable probe for studying aggregation mechanisms.

Purpose of the Study:

• To investigate the aggregation behavior of Aβ in a sodium dodecyl sulfate (SDS) environment using Congo Red (CR) as a probe.
• To elucidate the interaction site and mechanism of CR with Aβ.
• To explore the role of specific Aβ conformations in aggregation and potential therapeutic interventions for AD.

Main Methods:

• Utilized CR as a molecular probe to study Aβ aggregation in SDS conditions.
• Analyzed the structural conformations of Aβ(40) in the presence of SDS.
• Identified the interaction sites between CR and Aβ(40) using biophysical techniques (implied).

Main Results:

• Aβ(40) forms two short helical structures in the SDS environment.
• CR interacts with the helical form of Aβ(40), primarily at residues 17-25 (discordant helix region).
• CR stabilizes the helical conformation, preventing the α-helix to β-strand conversion and subsequent aggregation.

Conclusions:

• The discordant helix region (residues 17-25) plays a crucial role in stabilizing Aβ conformation in SDS.
• Stabilizing this discordant helical conformation can inhibit Aβ aggregation in membrane-associated states.
• This finding suggests a novel therapeutic strategy for Alzheimer's disease by targeting the stabilization of Aβ helical conformations.